Point-of-care biomarker testing to guide oral steroid treatment for acute asthma attacks in adults in primary care: the EPOCH trial (Eosinophil and Point-of-care FeNO-guided Care for T2-High Asthma)

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2026
This article has no abstract
Epistemonikos ID: 3beee8db93a792179f058fea3083aba2b8c9ef52
First added on: Jun 05, 2026